15-90760254-G-T
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PVS1PM2PP3PP5_Very_Strong
The NM_000057.4(BLM):c.1195G>T(p.Glu399*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000057.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Bloom syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine, Orphanet, Genomics England PanelApp, ClinGen
- osteosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- hereditary nonpolyposis colon cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000057.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BLM | NM_000057.4 | MANE Select | c.1195G>T | p.Glu399* | stop_gained | Exon 6 of 22 | NP_000048.1 | ||
| BLM | NM_001287246.2 | c.1195G>T | p.Glu399* | stop_gained | Exon 7 of 23 | NP_001274175.1 | |||
| BLM | NM_001287247.2 | c.1195G>T | p.Glu399* | stop_gained | Exon 6 of 20 | NP_001274176.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BLM | ENST00000355112.8 | TSL:1 MANE Select | c.1195G>T | p.Glu399* | stop_gained | Exon 6 of 22 | ENSP00000347232.3 | ||
| BLM | ENST00000560509.5 | TSL:1 | c.1195G>T | p.Glu399* | stop_gained | Exon 6 of 20 | ENSP00000454158.1 | ||
| BLM | ENST00000559724.5 | TSL:1 | n.*119G>T | non_coding_transcript_exon | Exon 6 of 22 | ENSP00000453359.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Bloom syndrome Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant has not been reported in the literature in individuals affected with BLM-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu399*) in the BLM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BLM are known to be pathogenic (PMID: 17407155).
Hereditary cancer-predisposing syndrome Pathogenic:1
This variant is a single nucleotide substitution in exon 6 of the BLM mRNA -c.(1195G>T). This sequence change creates a premature translational stop signal p.(Glu399*). It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BLM are known to be pathogenic (PMID:17407155). This variant is not present in population databases and it has not been reported in the literature in individuals affected with BLM-related disorders . ClinVar contains an entry for this variant (VCV002111079.3). Based on the classification criteria set by the ACMG and AMP (PMID:25741868) this variant has been classified as pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at